Evidence map›Paper›PMID 35730685›Full record

ArticlemAbs

Antigenic landscapes on

Shweta Kailasan, Ravi Kant, Madeleine Noonan-Shueh, Tulasikumari Kanipakala, Grant Liao, Sergey Shulenin, Daisy W Leung, Richard A Alm, Rajan P Adhikari, Gaya K Amarasinghe and 2 more

Open access · goldAbstract read
In one paragraph

Article in mAbs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Mass spectrometry footprinting reveals how kinetic stabilizers counteract transthyretin dynamics altered by pathogenic mutations.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Shweta KailasanIntegrated BioTherapeutics, Rockville, USA.ORCID 0000-0003-0876-6812
Ravi KantDepartment of Chemistry, Washington University in St. Louis, St. Louis, USA.
Madeleine Noonan-ShuehIntegrated BioTherapeutics, Rockville, USA.
Tulasikumari KanipakalaIntegrated BioTherapeutics, Rockville, USA.
Grant LiaoIntegrated BioTherapeutics, Rockville, USA.
Sergey ShuleninIntegrated BioTherapeutics, Rockville, USA.
Daisy W LeungDepartment of Medicine, Washington University in St. Louis, St. Louis, USA.
Richard A AlmBoston University School of Law, Boston University, Boston, USA.
Rajan P AdhikariIntegrated BioTherapeutics, Rockville, USA.
Gaya K AmarasingheDepartment of Pathology and Immunology, Washington University in St. Louis, St. Louis, USA.
Michael L GrossDepartment of Chemistry, Washington University in St. Louis, St. Louis, USA.
M Javad AmanIntegrated BioTherapeutics, Rockville, USA.
Integrated BioTherapeutics (United States) · USWashington University in St. Louis · USBoston University · US

Funding

Virology BSL4 CoreP01AI120943 · NIAID · WASHINGTON UNIVERSITY · PI Gaya K. Amarasinghe · 2016 to 2026
$30.2M
TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
Mechanisms of actin cytoskeleton modulation by PneumovirusesR01AI140758 · NIAID · UNIVERSITY OF KENTUCKY · PI DUTCH, REBECCA E., LEUNG, DAISY W · 2018 to 2022
$3.3M
A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical ProjectsR24GM136766 · NIGMS · WASHINGTON UNIVERSITY · PI GROSS, MICHAEL L · 2020 to 2022
$2.3M
Multi-platform High Throughput Screens for Filoviral Replication InhibitorsR01AI123926 · NIAID · WASHINGTON UNIVERSITY · PI AMARASINGHE, GAYA K. · 2016 to 2018
$2.1M
NIAID NIH HHS P01 AI120943NIAID NIH HHS R01 AI123926NIAID NIH HHS R01 AI140758NIGMS NIH HHS P41 GM103422NIGMS NIH HHS R24 GM136766Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Staphylococcal InfectionsStaphylococcus aureusAntibodies, MonoclonalBacterial ProteinsEpitopesExotoxinsHemolysin ProteinsHumansLeukocidinsVirulence FactorsAntibodies, MonoclonalBacterial ProteinsEpitopesExotoxinsHemolysin ProteinsLeukocidinsVirulence Factorsepitope mappinghydrogen/deuterium exchange mass spectrometryleukocidinmonoclonal antibodiesMRSApneumoniaStaphylococcus aureusΑ-hemolysin

Identifiers

PMID35730685
PMCPMC9225675
OpenAlexW4283328356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.